Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Allmed Medical Products Co.,Ltd (002950.SZ)
CNY9.19
+0.29 (+3.26%)
CN SHZ Healthcare Medical - Specialties
Address
Taurus Plaza, Block A 518052
Shenzhen, SH, CN
Shenzhen, SH, CN
CEO
Li Jun
Website
allmed-china.com
IPO
2019-03-11
ISIN CNE100003JM5
Description
Allmed Medical Products Co., Ltd. engages in the research, development, production and sales of disposable medical consumables. Its products include woven gauze swabs, non-woven swabs, elastic bandage, petrolatum gauze dress, oil emulsion dressing, eye pads, sponges, OR towels, kits, disposable drapes, dry, wet wipes, surgical gown, shoes and boot covers. The company was founded in 1992 and is headquartered in Zhijiang, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY9.19
+0.29 (+3.26%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
18M
Beta
0.24
Float Shares
488.17M
Free Float %
77.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.90% | -7.28% | -28.02% | -10.13% | -14.09% | -8.97% | +13.99% | -11.25% | -50.72% | -6.14% | -6.14% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
9.19
DCF (Unlevered)
14.04
+52.8%
DCF (Levered)
20.60
+124.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.51
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Specialties: +8.3%+10.4% ★ Q1'26: +18.1% (vs Q1'25)
-
EPS growth Medical - Specialties: +10.1%-32.2% Q1'26: +28.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Specialties: +51.3%+12.1% Q1'26: -1.7% (vs Q1'25)
-
EBIT margin Medical - Specialties: +12.6%+16.2% ★ Q1'26: +15.2% (vs Q1'25)
-
ROIC Medical - Specialties: +6.6%+14.5% ★ Q1'26: +11.9% (vs Q1'25)
-
Share dilution Medical - Specialties: 0.0%-1.0% ★ Q1'26: -2.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×0.92× Q1'26: 1.81× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
2.35B
est: 2.46B (-4.3%)
|
3.83B
est: 3.48B (+10.1%)
|
3.61B
est.
|
2.93B
est: 4.28B (-31.6%)
|
3.67B
est: 2.46B (+49.4%)
|
3.48B
3.48B – 3.48B
+41.7% YoY
|
3.61B
3.61B – 3.61B
+3.7% YoY
|
4.28B
4.28B – 4.28B
+18.3% YoY
|
| EBITDA |
558.22M
est: 568.96M (-1.9%)
|
1.50B
est: 806.49M (+85.8%)
|
836.54M
est.
|
673.88M
est: 990.01M (-31.9%)
|
831.92M
est: 489.34M (+70.0%)
|
693.63M
693.63M – 693.63M
+41.7% YoY
|
719.47M
719.47M – 719.47M
+3.7% YoY
|
851.46M
851.46M – 851.46M
+18.3% YoY
|
| EBIT |
436.85M
est: 428.68M (+1.9%)
|
1.36B
est: 607.66M (+123.2%)
|
630.29M
est.
|
528.76M
est: 745.92M (-29.1%)
|
594.90M
est: 337.15M (+76.4%)
|
477.91M
477.91M – 477.91M
+41.7% YoY
|
495.71M
495.71M – 495.71M
+3.7% YoY
|
586.66M
586.66M – 586.66M
+18.3% YoY
|
| Net Income |
325.81M
est: 316.61M (+2.9%)
|
1.16B
est: 354.10M (+226.9%)
|
456.16M
est.
|
431.21M
est: 487.41M (-11.5%)
|
248.88M
est: 313.53M (-20.6%)
|
350.66M
350.66M – 350.66M
+11.8% YoY
|
451.73M
451.73M – 451.73M
+28.8% YoY
|
482.67M
482.67M – 482.67M
+6.8% YoY
|
| SGA |
343.49M
est: 73.74M (+365.8%)
|
286.51M
est: 104.53M (+174.1%)
|
108.42M
est.
|
367.52M
est: 128.31M (+186.4%)
|
368.38M
est: 287.49M (+28.1%)
|
407.51M
407.51M – 407.51M
+41.7% YoY
|
422.70M
422.70M – 422.70M
+3.7% YoY
|
500.24M
500.24M – 500.24M
+18.3% YoY
|
| EPS |
0.53
est: 0.51 (+4.6%)
|
1.83
est: 0.57 (+222.9%)
|
0.73
est.
|
0.68
est: 0.78 (-12.8%)
|
0.40
est: 0.51 (-21.1%)
|
0.57
0.57 – 0.57
+11.8% YoY
|
0.73
0.73 – 0.73
+28.8% YoY
|
0.78
0.78 – 0.78
+6.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
533.90M
OE per share TTM
0.85
Owner's Yield
8.73%
Maintenance CapEx ratio
11.66%
Maint CapEx / Avg PPE
51.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 5 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 252.5K | 0.39% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 39.4K | 0.46% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 96.9K | 0.29% |
| 4 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 5.8K | 0.44% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 64.9K | 0.28% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
119.8K
Shares Outstanding
633.27M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chunjing Chen | Vice President | — | female |
| Dongning Cui | Vice President, Head of the Domestic Medical Business Group & Non-Independent Director | — | male |
| Huiqing Jia | Vice President & Director | — | male |
| Jinhai Cui | Chairman of the Board & President | — | male |
| Tiezhu Huang | Vice President & Chief Financial Officer | — | male |
| Tongshan Chen | Accounting Supervisor | — | — |
| Xiaocheng Zheng | Company Secretary | — | male |
| Xiumei Yang | Supervisor & GM of Finance Dept. of Domestic Medical Business Group | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002950.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
